Maryland Statutes
§ 13-3501
Maryland § 13-3501
This text of Maryland § 13-3501 is published on Counsel Stack Legal Research, covering Maryland primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Md. Code Ann., Health - General § 13-3501 (2026).
Text
(a)In this subtitle the following words have the meanings indicated.
(b)“Co–prescribing” means, with respect to an opioid overdose reversal drug, the practice of prescribing the drug in conjunction with an opioid prescription for a patient at an elevated risk of overdose.
(c)“Opioid overdose reversal drug” means naloxone or a similarly acting and equally safe drug that is approved by the federal Food and Drug Administration for the treatment of a known or suspected opioid overdose.
Free access — add to your briefcase to read the full text and ask questions with AI
Nearby Sections
15
Cite This Page — Counsel Stack
Bluebook (online)
Maryland § 13-3501, Counsel Stack Legal Research, https://law.counselstack.com/statute/md/ghg/13-3501.